Dr. Howard Smith Reports

Vidcast:  https://youtu.be/3xdNrOVHd9Y

The FDA and Maine Grains, Inc. are recalling Organic Yellow Peas sold between 10/17 and 11/1/2020.  This product may contain undeclared soybeans.  Those with a soybean allergy may develop a severe or life-threatening reaction if they ingest the yellow peas.  This product was distributed throughout the northeastern US and via mainegrains.com.   Much of the product was consumed in NYC.  If you purchased this product, return it to the store for a full refund.  If you have additional questions, call Maine Grains at 1-207-457-8001.

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/maine-grains-inc-issues-allergy-alert-undeclared-soy-organic-yellow-peas

#peas #maine #soybeans

Vidcast:  https://youtu.be/3xdNrOVHd9Y

The FDA and Maine Grains, Inc. are recalling Organic Yellow Peas sold between 10/17 and 11/1/2020.  This product may contain undeclared soybeans.  Those with a soybean allergy may develop a severe or life-threatening reaction if they ingest the yellow peas.  This product was distributed throughout the northeastern US and via mainegrains.com.   Much of the product was consumed in NYC.  If you purchased this product, return it to the store for a full refund.  If you have additional questions, call Maine Grains at 1-207-457-8001.

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/maine-grains-inc-issues-allergy-alert-undeclared-soy-organic-yellow-peas

#peas #maine #soybeans

Vidcast:  https://youtu.be/OeLW7r3CpCc

The CPSC and CB2 have recalled CB2 Chests and Dressers.  These pieces of furniture may tip over and injure children if not anchored to the wall. 11,000 were sold in the US and 355 sold in Canada.   If you have one of these at home, unload it and/or move it to a location away from access by children until you have anchored it to the call.  Alternatively, contact CB2 at 1-800-451-8217 to receive store credit or a refund.

https://www.cpsc.gov/Recalls/2021/CB2-Recalls-Junction-Tall-Chests-and-Low-Dressers-Due-to-Tip-Over-and-Entrapment-Hazards

#cb2 #dresser #chest #tipover

Vidcast:  https://youtu.be/OeLW7r3CpCc

The CPSC and CB2 have recalled CB2 Chests and Dressers.  These pieces of furniture may tip over and injure children if not anchored to the wall. 11,000 were sold in the US and 355 sold in Canada.   If you have one of these at home, unload it and/or move it to a location away from access by children until you have anchored it to the call.  Alternatively, contact CB2 at 1-800-451-8217 to receive store credit or a refund.

https://www.cpsc.gov/Recalls/2021/CB2-Recalls-Junction-Tall-Chests-and-Low-Dressers-Due-to-Tip-Over-and-Entrapment-Hazards

#cb2 #dresser #chest #tipover

Vidcast:  https://youtu.be/lzF-NFY8ok0

From the actual documents the company submitted to the FDA and CDC.  The Pfizer-BioNTech Vaccine consists of messenger RNA wrapped up in a lipid nanoparticle package.  The RNA is formulated to avoid immune destruction once injected and to code for a CoVid spike glycoprotein that will provoke production of a human antibody.  It is stored as a frozen suspension at -112 to -76 degrees Fahrenheit.   It is supplied in a 5-7 dose vial and is given as two 30 ug IM injections 28 days apart.  The vaccine is preservative-free and contains no eggs or latex

The Pfizer vaccine was first tested for safety and immunogenicity in a phase 1 trial of 90 persons and a followup phase 2 trial of 360 persons.  It’s effectiveness was confirmed and safety checked in a randomized blinded phase 3 trial involving 38,000  participants.  

The results showed an ability to prevent any CoVid infection for all age patients of 95%, for those 18-64 yrs of 95%, and for those 65-74 was 93%, and for those 75 and older of 100%.  No severe or fatal CoVid cases occurred in those vaccinated.  Vaccine efficiency for those receiving only one dose was 52%.  

The most common adverse local reaction was injection site pain in about 80%, There was swelling of armpit lymph noses occurred in 6%.

The 3 most common systemic adverse response were fatigue lasting up to 2 days in 60%, headache in 52%, muscle aches in 37%, joint pain in 22%, chills in 35%, and fever in 15%.

Though its overall effectiveness appears to be reduced for some new CoVid strains, it almost certainly will prevent severe CoVid infections and death due to these as well as due to the original CoVid strain.   Get vaccinated!

https://www.fda.gov/media/144416/download

https://www.fda.gov/media/144245/download

#pfizer #vaccine #CoVid

Vidcast:  https://youtu.be/lzF-NFY8ok0

From the actual documents the company submitted to the FDA and CDC.  The Pfizer-BioNTech Vaccine consists of messenger RNA wrapped up in a lipid nanoparticle package.  The RNA is formulated to avoid immune destruction once injected and to code for a CoVid spike glycoprotein that will provoke production of a human antibody.  It is stored as a frozen suspension at -112 to -76 degrees Fahrenheit.   It is supplied in a 5-7 dose vial and is given as two 30 ug IM injections 28 days apart.  The vaccine is preservative-free and contains no eggs or latex

The Pfizer vaccine was first tested for safety and immunogenicity in a phase 1 trial of 90 persons and a followup phase 2 trial of 360 persons.  It’s effectiveness was confirmed and safety checked in a randomized blinded phase 3 trial involving 38,000  participants.  

The results showed an ability to prevent any CoVid infection for all age patients of 95%, for those 18-64 yrs of 95%, and for those 65-74 was 93%, and for those 75 and older of 100%.  No severe or fatal CoVid cases occurred in those vaccinated.  Vaccine efficiency for those receiving only one dose was 52%.  

The most common adverse local reaction was injection site pain in about 80%, There was swelling of armpit lymph noses occurred in 6%.

The 3 most common systemic adverse response were fatigue lasting up to 2 days in 60%, headache in 52%, muscle aches in 37%, joint pain in 22%, chills in 35%, and fever in 15%.

Though its overall effectiveness appears to be reduced for some new CoVid strains, it almost certainly will prevent severe CoVid infections and death due to these as well as due to the original CoVid strain.   Get vaccinated!

https://www.fda.gov/media/144416/download

https://www.fda.gov/media/144245/download

#pfizer #vaccine #CoVid

Vidcast:  https://youtu.be/gyHNlHNrOLc

From the actual documents the company submitted to the FDA and CDC.  The Moderna Vaccine consists of messenger RNA wrapped up in a lipid nanoparticle package.  The RNA is formulated to avoid immune destruction once injected and to code for a CoVid spike glycoprotein that will provoke production of a human antibody.  It is stored as a frozen suspension at -13 to 5 degrees Fahrenheit.   It is supplied in a 10 dose vial and is given as two 100 ug IM injections 28 days apart.   The vaccine does not contain eggs, preservatives, or latex.

It was first tested for safety and immunogenicity in a phase 1 trial of 120 persons and a fu phase 2 trial of 600 persons.  It’s effectiveness was confirmed and safety checked in a randomized blinded phase 3 trial involving 30,000 participants.  

The results showed an ability to prevent any CoVid infection for all age patients of 94%, for those 18-64 yrs of 96%, and for those 65 and older of 86%.  No severe or fatal CoVid cases occurred in those vaccinated.  Vaccine efficiency for those receiving only one dose was 43%.  

The most common adverse local reaction was injection site pain in 88 to 90%.  Swelling of armpit lymph noses occurred in 12% to 16%.

The 3 most common systemic adverse response were fatigue 68%, headache in 63%, muscle aches in 60%, joint pain in 45%, chills in 43%, and fever in 15%.

Though its overall effectiveness appears to be reduced for some new CoVid strains, it almost certainly will prevent severe CoVid infections and death due to these as well as due to the original CoVid strain.   Get vaccinated!

https://www.fda.gov/media/144434/download

https://www.fda.gov/media/144673/download

#moderna #vaccine #CoVid

Vidcast:  https://youtu.be/gyHNlHNrOLc

From the actual documents the company submitted to the FDA and CDC.  The Moderna Vaccine consists of messenger RNA wrapped up in a lipid nanoparticle package.  The RNA is formulated to avoid immune destruction once injected and to code for a CoVid spike glycoprotein that will provoke production of a human antibody.  It is stored as a frozen suspension at -13 to 5 degrees Fahrenheit.   It is supplied in a 10 dose vial and is given as two 100 ug IM injections 28 days apart.   The vaccine does not contain eggs, preservatives, or latex.

It was first tested for safety and immunogenicity in a phase 1 trial of 120 persons and a fu phase 2 trial of 600 persons.  It’s effectiveness was confirmed and safety checked in a randomized blinded phase 3 trial involving 30,000 participants.  

The results showed an ability to prevent any CoVid infection for all age patients of 94%, for those 18-64 yrs of 96%, and for those 65 and older of 86%.  No severe or fatal CoVid cases occurred in those vaccinated.  Vaccine efficiency for those receiving only one dose was 43%.  

The most common adverse local reaction was injection site pain in 88 to 90%.  Swelling of armpit lymph noses occurred in 12% to 16%.

The 3 most common systemic adverse response were fatigue 68%, headache in 63%, muscle aches in 60%, joint pain in 45%, chills in 43%, and fever in 15%.

Though its overall effectiveness appears to be reduced for some new CoVid strains, it almost certainly will prevent severe CoVid infections and death due to these as well as due to the original CoVid strain.   Get vaccinated!

https://www.fda.gov/media/144434/download

https://www.fda.gov/media/144673/download

#moderna #vaccine #CoVid

Vidcast:  https://youtu.be/2olR_GBnm0I

This observation suggests we can save precious CoVid vaccine supplies say virologists and epidemiologists at the University of Maryland.  They suggest this strategy after testing 33 health care workers with proven, previous CoVid infections and 26 uninfected workers.

The data reveals that those with pre-existing anti-CoVid antibodies respond to a first dose of either the Moderna or Pfizer vaccine with an anti-spike antibody peak similar to those receiving a second dose of the vaccine.  Given that those previously infected have some CoVid immunity and pre-existing anti-CoVid antibodies after either a symptomatic or asymptomatic infection, they need only receive  a single dose of a 2-dose vaccine.

https://www.medrxiv.org/content/10.1101/2021.01.30.21250843v1.full.pdf

#CoVid #vaccine #infected

Vidcast:  https://youtu.be/2olR_GBnm0I

This observation suggests we can save precious CoVid vaccine supplies say virologists and epidemiologists at the University of Maryland.  They suggest this strategy after testing 33 health care workers with proven, previous CoVid infections and 26 uninfected workers.

The data reveals that those with pre-existing anti-CoVid antibodies respond to a first dose of either the Moderna or Pfizer vaccine with an anti-spike antibody peak similar to those receiving a second dose of the vaccine.  Given that those previously infected have some CoVid immunity and pre-existing anti-CoVid antibodies after either a symptomatic or asymptomatic infection, they need only receive  a single dose of a 2-dose vaccine.

https://www.medrxiv.org/content/10.1101/2021.01.30.21250843v1.full.pdf

#CoVid #vaccine #infected